Ledger.Open graph →
SEC Form D · Amendment · filed May 25, 2023

Slate Bio, Inc

Offering
$3.0M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
CHARLOTTESVILLE, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Andrew Krouse · Charlottesville, VAExec · DirectorBrian Gallagher · Charlottesville, VADirectorKyparissia Sirinakis · Charlottesville, VADirectorKurt Woerpel · Charlottesville, VAExecRobert Creeden · Charlottesville, VADirectorJames Hodges · Tempe, AZExecMicah Cabagbag · Houston, TXDirectorDavid Langer · Tempe, AZDirectorJoseph A. Lanasa Iii · West Palm Beach, FLExec · DirectorTheodore S. Kokernak · Los Altos, CADirectorTom Adamson · Minnetonka, MNExec · DirectorTodd Schroeder · Minnetonka, MNDirectorSee Clarification See Clarification · London, United KingdomExecAndrew Argue · Palm Beach Gardens, FLDirectorSachneel Patel · San Jose, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗